Ibrance 75 MG tablet 7S
Ended Awarded
- Contract number
- SPE2DB25FEHZN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,744
Award facts
- Contract value 100% obligated
- $48,743.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $48,743.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg tablets (quantity 7) on September 24, 2025, with an ultimate completion date of October 16, 2025. This non-competitive, non-set-aside delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical contract vehicle provides the flexibility needed to fulfill ongoing pharmaceutical supply requirements across the military medical supply chain, with AmerisourceBergen positioned as a key vendor within the Defense Logistics Agency's pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DB25FEHZN?
SPE2DB25FEHZN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FEHZN worth?
The government has obligated $48,744 on SPE2DB25FEHZN.
Is contract SPE2DB25FEHZN an order under another contract?
Yes. SPE2DB25FEHZN is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHZN competed?
The extent of competition for SPE2DB25FEHZN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award